Nadine Norton

17.6k total citations
108 papers, 5.9k citations indexed

About

Nadine Norton is a scholar working on Molecular Biology, Genetics and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Nadine Norton has authored 108 papers receiving a total of 5.9k indexed citations (citations by other indexed papers that have themselves been cited), including 53 papers in Molecular Biology, 37 papers in Genetics and 29 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Nadine Norton's work include Genetic Associations and Epidemiology (22 papers), Genetics and Neurodevelopmental Disorders (19 papers) and HER2/EGFR in Cancer Research (16 papers). Nadine Norton is often cited by papers focused on Genetic Associations and Epidemiology (22 papers), Genetics and Neurodevelopmental Disorders (19 papers) and HER2/EGFR in Cancer Research (16 papers). Nadine Norton collaborates with scholars based in United Kingdom, United States and Australia. Nadine Norton's co-authors include Michael J. Owen, Michael O’Donovan, Nigel Williams, Hywel Williams, George Kirov, Ray E. Hershberger, Duanxiang Li, Gillian Spurlock, Stanley Zammit and Jill D. Siegfried and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and Circulation.

In The Last Decade

Nadine Norton

107 papers receiving 5.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nadine Norton United Kingdom 45 2.8k 2.2k 1.1k 1.1k 832 108 5.9k
Maria Karayiorgou United States 38 4.0k 1.5× 2.9k 1.3× 203 0.2× 2.0k 1.8× 653 0.8× 63 7.0k
Sven Cichon Germany 50 2.8k 1.0× 3.1k 1.4× 189 0.2× 1.7k 1.6× 2.0k 2.4× 217 8.8k
Maria Karayiorgou United States 34 2.9k 1.1× 1.6k 0.7× 127 0.1× 1.5k 1.4× 633 0.8× 63 5.5k
Hywel Williams United Kingdom 37 1.8k 0.7× 1.7k 0.8× 113 0.1× 709 0.6× 679 0.8× 101 4.2k
Wolfgang Berger Switzerland 46 4.5k 1.6× 1.3k 0.6× 320 0.3× 1.2k 1.1× 129 0.2× 172 7.0k
Herbert M. Lachman United States 43 3.1k 1.1× 1.8k 0.8× 137 0.1× 1.7k 1.6× 1.7k 2.1× 107 7.4k
Michael Knapp Germany 43 1.9k 0.7× 2.4k 1.1× 105 0.1× 1.1k 1.0× 660 0.8× 147 5.2k
Judith A. Badner United States 33 2.2k 0.8× 2.6k 1.2× 99 0.1× 530 0.5× 1.1k 1.3× 73 5.3k
Ramona M. Rodriguiz United States 44 3.1k 1.1× 1.2k 0.5× 116 0.1× 2.6k 2.4× 533 0.6× 99 6.6k
Margaret A. Pericak‐Vance United States 31 1.5k 0.5× 1.9k 0.8× 148 0.1× 590 0.5× 678 0.8× 45 4.6k

Countries citing papers authored by Nadine Norton

Since Specialization
Citations

This map shows the geographic impact of Nadine Norton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nadine Norton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nadine Norton more than expected).

Fields of papers citing papers by Nadine Norton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nadine Norton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nadine Norton. The network helps show where Nadine Norton may publish in the future.

Co-authorship network of co-authors of Nadine Norton

This figure shows the co-authorship network connecting the top 25 collaborators of Nadine Norton. A scholar is included among the top collaborators of Nadine Norton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nadine Norton. Nadine Norton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Norton, Nadine, et al.. (2021). Sex Differences, Genetic and Environmental Influences on Dilated Cardiomyopathy. Journal of Clinical Medicine. 10(11). 2289–2289. 33 indexed citations
2.
Li, Liping, Meihang Li, Yuanchao Sun, et al.. (2021). Disruption of MAP7D1 Gene Function Increases the Risk of Doxorubicin‐Induced Cardiomyopathy and Heart Failure. BioMed Research International. 2021(1). 8569921–8569921. 7 indexed citations
3.
Knutson, Keith L., Matthew S. Block, Nadine Norton, et al.. (2019). Rapid Generation of Sustainable HER2-specific T-cell Immunity in Patients with HER2 Breast Cancer using a Degenerate HLA Class II Epitope Vaccine. Clinical Cancer Research. 26(5). 1045–1053. 11 indexed citations
4.
Norton, Nadine, Kathleen Tenner, Karla V. Ballman, et al.. (2018). Generation of HER2-specific antibody immunity during trastuzumab adjuvant therapy associates with reduced relapse in resected HER2 breast cancer. Breast Cancer Research. 20(1). 52–52. 11 indexed citations
5.
Knowles, David A., Courtney K. Burrows, John Blischak, et al.. (2018). Determining the genetic basis of anthracycline-cardiotoxicity by molecular response QTL mapping in induced cardiomyocytes. eLife. 7. 71 indexed citations
6.
Knutson, Keith L., Raphael Clynes, Barath Shreeder, et al.. (2016). Improved Survival of HER2+ Breast Cancer Patients Treated with Trastuzumab and Chemotherapy Is Associated with Host Antibody Immunity against the HER2 Intracellular Domain. Cancer Research. 76(13). 3702–3710. 47 indexed citations
7.
Perez, Edith A., Karla V. Ballman, Afshin Mashadi-Hossein, et al.. (2016). Intrinsic Subtype and Therapeutic Response Among HER2-Positive Breaty st Tumors from the NCCTG (Alliance) N9831 Trial. JNCI Journal of the National Cancer Institute. 109(2). djw207–djw207. 27 indexed citations
8.
Norton, Nadine, Mark D. Pegram, Kathleen Tenner, et al.. (2014). Association Studies of Fcγ Receptor Polymorphisms with Outcome in HER2+ Breast Cancer Patients Treated with Trastuzumab in NCCTG (Alliance) Trial N9831. Cancer Immunology Research. 2(10). 962–969. 34 indexed citations
9.
Norton, Nadine & Edith A. Perez. (2013). How relevant is hormone receptor status in the context of outcome to HER2-positive breast cancer?. Breast Cancer Research. 15(1). 101–101. 3 indexed citations
10.
Norton, Nadine, Jill D. Siegfried, Duanxiang Li, & Ray E. Hershberger. (2011). Assessment of LMNA Copy Number Variation in 58 Probands with Dilated Cardiomyopathy. Clinical and Translational Science. 4(5). 351–352. 12 indexed citations
11.
Hamshere, Marian L., Peter Holmans, Geraldine McCarthy, et al.. (2011). Phenotype evaluation and genomewide linkage study of clinical variables in schizophrenia. American Journal of Medical Genetics Part B Neuropsychiatric Genetics. 156(8). 929–940. 12 indexed citations
12.
Pinto, José R., Jill D. Siegfried, Michelle S. Parvatiyar, et al.. (2011). Functional Characterization of TNNC1 Rare Variants Identified in Dilated Cardiomyopathy. Journal of Biological Chemistry. 286(39). 34404–34412. 48 indexed citations
13.
Kirov, George, Detelina Grozeva, Nadine Norton, et al.. (2009). Support for the involvement of large copy number variants in the pathogenesis of schizophrenia. Human Molecular Genetics. 18(8). 1497–1503. 284 indexed citations
14.
Phillips, Aled O., Nadine Norton, Gillian Spurlock, et al.. (2008). Further evidence for the association of MMP9 with nephropathy in type 2 diabetes and application of DNA pooling technology to candidate gene screening. Journal of Nephrology. 21(3). 400–405. 16 indexed citations
15.
Goossens, D., Noel N. Williams, Lien Heyrman, et al.. (2007). Gene copy number variation in schizophrenia. Schizophrenia Research. 96(1-3). 93–99. 50 indexed citations
16.
Zammit, Stanley, Gillian Spurlock, Hywel Williams, et al.. (2007). Genotype effects of CHRNA7, CNR1 and COMT in schizophrenia: interactions with tobacco and cannabis use . The British Journal of Psychiatry. 191(5). 402–407. 130 indexed citations
17.
Norton, Nadine, Hywel Williams, Sarah Dwyer, et al.. (2005). No evidence for association between polymorphisms in GRM3and schizophrenia. BMC Psychiatry. 5(1). 23–23. 43 indexed citations
18.
Bray, Nicholas J., Paul R. Buckland, Nigel Williams, et al.. (2003). A Haplotype Implicated in Schizophrenia Susceptibility Is Associated with Reduced COMT Expression in Human Brain. The American Journal of Human Genetics. 73(1). 152–161. 291 indexed citations
19.
Levinson, Douglas F., Peter Holmans, Richard E. Straub, et al.. (2000). Multicenter Linkage Study of Schizophrenia Candidate Regions on Chromosomes 5q, 6q, 10p, and 13q: Schizophrenia Linkage Collaborative Group III. The American Journal of Human Genetics. 67(3). 652–663. 148 indexed citations
20.
Deb, Shoumitro, et al.. (1998). No significant association between a PS-1 intronic polymorphism and dementia in Down's syndrome. Bristol Research (University of Bristol). 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026